Table 2.
Response to IV ketamine
| Tumor Compression | CIPN | Postsurgical | Postradiation | Total | |
|---|---|---|---|---|---|
| Total number | n = 13 | n = 25 | n = 13 | n = 6 | N = 57 |
| Responders, n (%) | 9 (69.2) | 21 (84.0) | 9 (69.2) | 3 (50.0) | 42 (73.7) |
| Pain/adverse event–limited(% of total responders) | 3 (33.3) | 4 (19.0) | 4 (44.4) | 1 (33.3) | 12 (26.7) |
| Nonresponders, n (%) | 4 (30.8) | 4 (16.0) | 4 (30.8) | 3 (50.0) | 15 (26.3) |
| P value | 0.17 | <0.01 | 0.17 | 1.00 | <0.01 |
Pain/adverse event–limited refers to patients who came off the IV ketamine program, despite pain relief, because of an infusion-related adverse event or because subsequent infusions resulted in reduced efficacy.